Neonatal Jaundice at a District Hospital Without Exchange Transfusion
A 5-day-old term male, birth weight 3.1 kg, exclusively breastfed, is brought to a district hospital in a setting where exchange transfusion and intensive phototherapy are unavailable; the nearest neonatal unit is 6 hours away by road, and the ambulance is currently out on another call. He is jaundiced to the palms and soles, awake but sleepy, feeding poorly since yesterday, with two wet nappies in 24 hours. Weight today is 2.85 kg. Total serum bilirubin is 22 mg/dL at 14:00, measured on a device that the lab reports as reliable; direct fraction is 0.8 mg/dL. He has no fever, no hepatosplenomegaly, and no cephalhaematoma. Mother is blood group O positive, baby is O positive, and the direct antiglobulin test is negative. The mother asks whether she can just take him home and bring him back tomorrow.
1. Identify the features in this presentation that indicate severe hyperbilirubinaemia and explain the physiological mechanisms that make this infant particularly vulnerable to bilirubin encephalopathy.
Read the worked answer
The bilirubin of 22 mg/dL at day 5 in a term infant exceeds the usual phototherapy threshold and approaches exchange transfusion territory, particularly with the rapid rise implied by poor feeding and dehydration. Several features compound the risk:
- Dehydration and reduced intake: only two wet nappies in 24 hours and 250 g weight loss (about 8%) reduce bilirubin clearance and increase enterohepatic recirculation, since less meconium/stool is passed and more bilirubin is deconjugated by gut beta-glucuronidase and reabsorbed.
- Jaundice to palms and soles: this indicates a high total bilirubin and suggests a significant unconjugated fraction.
- Sleepiness and poor feeding: these are early neurological signs of bilirubin toxicity, not merely a feeding problem.
- Low albumin binding capacity: in a dehydrated, poorly feeding neonate, fewer binding sites are available, so more free (unbound) bilirubin crosses an immature blood-brain barrier.
- Immature hepatic conjugation: at day 5, uridine diphosphate glucuronosyltransferase activity is still maturing, so clearance lags production.
The negative direct antiglobulin test and ABO-compatible mother/baby pair make immune haemolysis less likely, but do not exclude it, and do not reduce the risk from the bilirubin level itself. The key judgement is that a level of 22 mg/dL with neurological signs is a medical emergency requiring immediate treatment, not a home trial.
2. Given that intensive phototherapy is unavailable on site and the ambulance is delayed, outline a prioritised management plan for the next 6 hours, including what you would do while awaiting transfer and what you would avoid.
Read the worked answer
The priority is to lower bilirubin and prevent bilirubin encephalopathy while arranging transfer. A reasonable sequence:
- Arrange urgent transfer to the neonatal unit with exchange transfusion capability; document the time of the request and escalate to the referral centre and ambulance control. Do not wait for the ambulance before starting treatment.
- Start conventional phototherapy immediately if any unit is available, even if not "intensive" - blue-green light at maximum irradiance, maximal skin exposure, eye protection, and continuous monitoring. Conventional phototherapy is better than none.
- Correct dehydration and establish feeding: intravenous fluids if the baby cannot feed, or expressed breast milk by cup if suck is poor. Adequate hydration improves bilirubin clearance and reduces free bilirubin.
- Do not delay transfer to observe a repeat bilirubin; a repeat level can be taken but must not gate the decision.
- Avoid harmful practices: do not give supplementary water or glucose water (no bilirubin-lowering benefit, risks hyponatraemia and reduces milk intake); do not use drugs such as phenobarbitone or agar expecting a meaningful acute effect; do not rely on sunlight.
- Monitor for lethargy, poor suck, hypertonia, retrocollis or a high-pitched cry, which would mandate the fastest possible transfer.
- Communicate with the mother honestly: this is a treatable but time-critical condition, and the reason for transfer is the risk of brain injury, not a routine check.
3. The mother says her neighbour's baby "also looked yellow" and was fine without treatment. How would you address this, and what follow-up would you plan if transfer is refused?
Read the worked answer
This is a consent and risk-communication problem as much as a clinical one. The neighbour's baby is not comparable: jaundice is common and often benign, but severity, timing, feeding and neurological signs determine risk. I would explain, in plain terms, that this baby's bilirubin is in the range where brain damage (kernicterus) can occur, that sleepiness and poor feeding are warning signs, and that treatment is time-critical.
I would explore the reasons for refusal - cost, transport, other children at home, fear - and address them concretely (e.g., arranging transport, involving a social worker, contacting relatives). I would involve a senior clinician and, where the child's life is at risk and the parent refuses necessary treatment, follow local child protection and legal escalation pathways; refusal of life-saving treatment for a minor is not simply a parental choice.
If transfer is genuinely impossible, I would provide the best available on-site care: maximal phototherapy, hydration, frequent feeding, and continuous observation, with a documented plan and repeat bilirubin. I would not discharge the baby home. Follow-up would be in-hospital until bilirubin is falling and feeding is established, with neurodevelopmental review later, since early signs of bilirubin encephalopathy can be subtle.